Bosh sahifaBIOVF • OTCMKTS
add
Swedish Orphan Biovitrum AB (publ)
Yopilish kursi
28,30 $
Yillik diapazon
22,40 $ - 32,25 $
Bozor kapitalizatsiyasi
103,24 mlrd SEK
Oʻrtacha hajm
37,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 6,89 mlrd | 33,40% |
Joriy xarajat | 3,52 mlrd | 4,14% |
Sof foyda | 1,46 mlrd | 1 457,45% |
Sof foyda marjasi | 21,24 | 1 067,03% |
Har bir ulushga tushum | 4,31 | 713,21% |
EBITDA | 3,00 mlrd | 89,53% |
Amaldagi soliq stavkasi | 14,49% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 594,00 mln | -12,39% |
Jami aktivlari | 72,20 mlrd | -4,47% |
Jami passivlari | 35,09 mlrd | -14,71% |
Umumiy kapital | 37,11 mlrd | — |
Tarqatilgan aksiyalar | 343,44 mln | — |
Narxi/balansdagi bahosi | 0,26 | — |
Aktivlardan daromad | 7,15% | — |
Kapitaldan daromad | 9,59% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,46 mlrd | 1 457,45% |
Operatsiyalardan naqd pul | 1,20 mlrd | 13,52% |
Sarmoyadan naqd pul | -2,20 mlrd | -431,88% |
Moliyadan naqd pul | 860,00 mln | 211,11% |
Naqd pulning sof oʻzgarishi | -185,00 mln | -65,18% |
Boʻsh pul | -3,51 mlrd | -219,76% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 814
